Keyword: SARS-CoV-2

Lethal networks

Faced with an invasion of viruses or bacteria, human immune system cells sometimes overreact in a process known as NETosis, which has been shown to be more severe when the invader is SARS-CoV-2

Complex choices

Bioethics committees have become increasingly important in solving dilemmas brought about by the pandemic, but few hospitals have them

A town turned laboratory

Epidemiological studies, such as the one led in the town of Serrana, São Paulo, should provide valuable information about the pandemic

New vaccines on the way

Butantan Institute and federal government plan to start human trials of two vaccine candidates in the coming months

The evolution of a virus

Low vaccination rates and lack of control over SARS-CoV-2 circulation is increasing the likelihood that more transmissible and lethal variants will emerge

Death of a man; extinction of an ethnic group

Aruká Juma, the last person to speak the language of the Juma people, died of COVID-19 on February

A mask that inactivates the virus

Hospital Regional da Asa Norte in Brasília began clinical trials of a mask that contains a biocompatible compound capable of inactivating the novel coronavirus

High infant mortality in Sergipe

Despite having enough beds available in intensive care units (ICU) for adults, Sergipe has a 41% shortfall in pediatric beds

Understand the long-term effects

The US NIH announced a plan to invest US$1.15 billion over the next four years into research on the long-term effects of COVID-19

Outbreak on ship confirms the main route of contagion

The results of computer simulations of how COVID-19 spread on the Australian cruise ship Princess Diamond have finally been published in a scientific journal.

Research during quarantine

Poor performance

Brazil's response to the pandemic was considered the worst in the world by a survey released in January by the Lowy Institute, Australia

Life support

Brazilian firm develops native out-of-body oxygenation system for patients in critical condition

Eurico Arruda: Admirer of viruses

Coronavirus specialist and USP physician speaks about the new variants of SARS-CoV-2 and the risk they represent in the efficacy of some vaccines

The expected effect of vaccines

Administering vaccines on a large scaled will tell us whether, in addition to protecting against the disease, they are also able to prevent infection by SARS-CoV-2

Obstacle course

Research centers working on vaccines for the novel coronavirus in Brazil face major hurdles

Combat strategy

Research networks seeking to strengthen dialogue with the public authorities arise in response to the pandemic

Antibodies reduce deaths

A clinical trial led by researchers at the University of Oxford, UK, identified a second drug capable of reducing mortality among patients with severe COVID-19

Some more likely than others to leave the house

Middle and high earner are more willing to leave home to work during the pandemic than low earners, even at the risk of contracting the novel coronavirus

Declining infections and hospitalizations

Israel is already benefitting from the effects of vaccination against COVID-19

Concerning virus variations

In early 2021, information emerged on the rapid spread of new variants of SARS-CoV-2

Renewed momentum

The São Paulo institute strengthened itself, mobilized competencies, and integrated teams to face the pandemic

Dimas Covas: The trajectory of Butantan

The hematologist from USP readies the São Paulo institute to fight the pandemic and has plans to transform it into one of the world’s top producers of vaccines and serums

vaccine. Now what?

The introduction of vaccines in the battle against the COVID-19 pandemic raises new challenges

A more balanced game

Approved for emergency use, CoronaVac is the first vaccine to be offered in Brazil

COVID-19 outbreak started on a flight

Map shows the origin of passengers who showed symptoms of illness after the journey

A safer way to ride share

Always open car windows to reduce the risk of being infected by the novel coronavirus

Yes to the vaccine

On January 18, FAPESP started the #vacinasim (“yesvaccine”) social media campaign to reinforce public confidence in their safety and effectiveness

Immunity could be long-lasting

The immune system's ability to recognize the novel coronavirus and fight it seems to last for at least eight months

Lockdown and the city air

The strict social distancing measures adopted by governments to try to contain the spread of the pandemic have improved air quality in some of the world's major cities